| David E Werkmeister, MD | |
|
1025 Marsh St, Mankato, MN 56001-4752 | |
| (507) 345-2623 | |
| (507) 389-4685 |
| Full Name | David E Werkmeister |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 1025 Marsh St, Mankato, Minnesota |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164434189 | NPI | - | NPPES |
| 2001249 | Other | MEDICA | |
| 274S4WE | Other | MN | BLUE CROSS BLUE SHIELD |
| HP42455 | Other | HEALTH PARTNERS | |
| 967551030269 | Other | PREFERRED ONE | |
| 141557 | Other | UCARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | 44624 (Minnesota) | Primary |
| Entity Name | Mankato Surgical Center, L.l.c. |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1720161615 PECOS PAC ID: 2163564659 Enrollment ID: O20100121000534 |
News Archive
Researchers at MIT and Paris Descartes University have developed a new optogenetic technique that sculpts light to target individual cells bearing engineered light-sensitive molecules, so that individual neurons can be precisely stimulated.
Thomson Reuters has selected Erkki Ruoslahti, M.D., Ph.D., cancer researcher and distinguished professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), as one of its 2012 Citation Laureates. Citation Laureates are scientists that Thomson Reuters has predicted to win the Nobel Prize.
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.
Cytori Therapeutics received US Patent No. 8,404,229 (the '229 patent) for methods of treating renal diseases using adipose-derived regenerative cells (ADRCs).
› Verified 4 days ago
| Entity Name | Ams Maple Grove Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871913582 PECOS PAC ID: 8527287762 Enrollment ID: O20140919001422 |
News Archive
Researchers at MIT and Paris Descartes University have developed a new optogenetic technique that sculpts light to target individual cells bearing engineered light-sensitive molecules, so that individual neurons can be precisely stimulated.
Thomson Reuters has selected Erkki Ruoslahti, M.D., Ph.D., cancer researcher and distinguished professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), as one of its 2012 Citation Laureates. Citation Laureates are scientists that Thomson Reuters has predicted to win the Nobel Prize.
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.
Cytori Therapeutics received US Patent No. 8,404,229 (the '229 patent) for methods of treating renal diseases using adipose-derived regenerative cells (ADRCs).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David E Werkmeister, MD 57150 Jaguar Ln, Mankato, MN 56001-6769 Ph: () - | David E Werkmeister, MD 1025 Marsh St, Mankato, MN 56001-4752 Ph: (507) 345-2623 |
News Archive
Researchers at MIT and Paris Descartes University have developed a new optogenetic technique that sculpts light to target individual cells bearing engineered light-sensitive molecules, so that individual neurons can be precisely stimulated.
Thomson Reuters has selected Erkki Ruoslahti, M.D., Ph.D., cancer researcher and distinguished professor at Sanford-Burnham Medical Research Institute (Sanford-Burnham), as one of its 2012 Citation Laureates. Citation Laureates are scientists that Thomson Reuters has predicted to win the Nobel Prize.
Children with pelvic and thigh fractures develop dangerous blood clots so rarely that anti-clotting therapy should be given only to those with underlying conditions that increase clotting risk, according to a study from Johns Hopkins Children's Center.
Cytori Therapeutics received US Patent No. 8,404,229 (the '229 patent) for methods of treating renal diseases using adipose-derived regenerative cells (ADRCs).
› Verified 4 days ago
Paul L Johnson, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-345-2623 Fax: 507-389-4685 | |
Alyson Leigh Jasper, DNAP, APRN, CRNA Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 | |
David J Egli, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-345-2623 Fax: 507-389-4685 | |
David J Plevak, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-625-4031 Fax: 507-284-0120 | |
Robert Peter Diego, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1025 Marsh St, Mankato, MN 56001 Phone: 507-345-2623 Fax: 507-389-4685 | |
Ifechi Anyadioha, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1400 E. Madison Ave, Suite 402, Mankato, MN 56001 Phone: 507-625-7246 |